U.S. health officials are facing challenges in determining whether a Missouri person infected with H5N1 bird flu transmitted the virus to others. This delay...
Bluebird Bio, a once-promising biotech company, made headlines recently with its decision to sell itself and its portfolio of gene therapies to investment firms...